Loss of maternal chromosome 11 is a signature event in SDHAF2, SDHD, and VHL-related paragangliomas, but less significant in SDHB-related paragangliomas

Attje S. Hoekstra, Erik F. Hensen, Ekaterina S. Jordanova, Esther Korpershoek, Anouk N. A. van der Horst-Schrivers, Cees Cornelisse, Eleonora P. M. Corssmit, Frederik J. Hes, Jeroen C. Jansen, Henricus P. M. Kunst, Henri J. L. M. Timmers, Adrian Bateman, Diana Eccles, Judith V. M. G. Bovee, Peter Devilee, Jean-Pierre Bayley

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)14525-14536
JournalOncotarget
Volume8
Issue number9
DOIs
Publication statusPublished - 28 Feb 2017

Cite this

Hoekstra, A. S., Hensen, E. F., Jordanova, E. S., Korpershoek, E., van der Horst-Schrivers, A. N. A., Cornelisse, C., ... Bayley, J-P. (2017). Loss of maternal chromosome 11 is a signature event in SDHAF2, SDHD, and VHL-related paragangliomas, but less significant in SDHB-related paragangliomas. Oncotarget, 8(9), 14525-14536. https://doi.org/10.18632/oncotarget.14649